Mumbai, Jul 10 (UNI) The growth trajectory for Indian pharmaceutical industry is likely to be moderate, in single digit on the back of slowing growth ...
Read more: Persisting growth challenges in Indian pharma sector likely to curtail aggregate growth to single ...